Literature DB >> 1563213

Diuretic efficiency of furosemide during continuous administration versus bolus injection in healthy volunteers.

J J van Meyel1, P Smits, F G Russel, P G Gerlag, Y Tan, F W Gribnau.   

Abstract

Furosemide delivery rate in the nephron has been reported to be one of the major determinants of diuretic response. In a randomized, crossover double-blind study in eight healthy volunteers, we tested this hypothesis by comparing continuous intravenous infusion of furosemide (infusion rate, 4 mg/hr) during 8 hours after administration of an intravenous loading dose of 8 mg (total dose, 40 mg) with an intravenous bolus injection of 40 mg furosemide. During the study days subjects were rehydrated with isovolumetric amounts of fluid. Mean total urinary volume (Vur), sodium (UNa), potassium, and chloride excretion after 8 and 24 hours were significantly greater after treatment with continuous furosemide infusion when compared with bolus injection, whereas total urinary furosemide excretion showed no differences (Vur bolus versus Vur infusion, 5270 versus 6770 ml/8 hours; UNa bolus versus UNa infusion, 314 versus 430 mmol/8 hours; both p less than 0.001). These findings strongly support the concept of the furosemide delivery rate into the nephron as a determinant of diuretic efficiency.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1563213     DOI: 10.1038/clpt.1992.44

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  9 in total

1.  The influence of frusemide formulation on diuretic effect and efficiency.

Authors:  M Wakelkamp; A Blechert; M Eriksson; K Gjellan; C Graffner
Journal:  Br J Clin Pharmacol       Date:  1999-09       Impact factor: 4.335

2.  The influence of drug input rate on the development of tolerance to frusemide.

Authors:  M Wakelkamp; G Alván; H Scheinin; J Gabrielsson
Journal:  Br J Clin Pharmacol       Date:  1998-11       Impact factor: 4.335

Review 3.  The efficiency concept in pharmacodynamics.

Authors:  G Alván; G Paintaud; M Wakelkamp
Journal:  Clin Pharmacokinet       Date:  1999-05       Impact factor: 6.447

4.  Role of EDHF in the vasodilatory effect of loop diuretics in guinea-pig mesenteric resistance arteries.

Authors:  F Pourageaud; C Bappel-Gozalbes; R Marthan; J L Freslon
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

Review 5.  Loop diuretics in acute decompensated heart failure: necessary? Evil? A necessary evil?

Authors:  G Michael Felker; Christopher M O'Connor; Eugene Braunwald
Journal:  Circ Heart Fail       Date:  2009-01       Impact factor: 8.790

6.  Sensitivity of residual nephrons to high dose furosemide described by diuretic efficiency.

Authors:  R W van Olden; J J van Meyel; P G Gerlag
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

7.  Continuous versus intermittent use of furosemide in patients with heart failure and moderate chronic renal dysfunction.

Authors:  Zhigui Zheng; Xinxin Jiang; Jianguo Chen; Dongyuan He; Xiaohui Xie; Yunan Lu
Journal:  ESC Heart Fail       Date:  2021-03-10

8.  Randomized, open-label, blinded-endpoint, crossover, single-dose study to compare the pharmacodynamics of torasemide-PR 10 mg, torasemide-IR 10 mg, and furosemide-IR 40 mg, in patients with chronic heart failure.

Authors:  Maria Rosa Ballester; Eulàlia Roig; Ignasi Gich; Montse Puntes; Joaquín Delgadillo; Benjamín Santos; Rosa Maria Antonijoan
Journal:  Drug Des Devel Ther       Date:  2015-08-05       Impact factor: 4.162

9.  Sodium and Fluid Excretion With Torsemide in Healthy Subjects is Limited by the Short Duration of Diuretic Action.

Authors:  Salim Shah; Bertram Pitt; D Craig Brater; Peter U Feig; Wen Shen; Fatima S Khwaja; Christopher S Wilcox
Journal:  J Am Heart Assoc       Date:  2017-10-05       Impact factor: 5.501

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.